CD4 and neoplasm: Taken together, these results suggest that the strong antitumor effect elicited by RdB/IL12/shVEGF is associated with markedly enhanced infiltration and activation of CD4+ T, CD8+ T, DC, and NK cells to tumor tissue and concurrent inhibition of immunosuppressive Treg accumulation.